Welcome to our dedicated page for The Cigna Group news (Ticker: CI), a resource for investors and traders seeking the latest updates and insights on The Cigna Group stock.
The Cigna Group (NYSE: CI) is a global health services company dedicated to improving health outcomes and providing comprehensive healthcare solutions. The company operates primarily through two platforms: Evernorth Health Services and Cigna Healthcare. Cigna offers a diverse portfolio of pharmacy, medical, behavioral, dental, and supplemental products and services.
Pharmacy Benefit Management (PBM) and Health Insurance: Cigna's PBM services experienced significant growth following its 2018 merger with Express Scripts. The company's PBM and specialty pharmacy services are primarily sold to health insurance plans and employers, with notable contracts including the Department of Defense and insurer Centene. Cigna serves 18 million U.S. medical members as of December 2023, focusing on self-funded employer arrangements.
Recent Achievements: In 2024, Cigna repurchased $3.2 billion of common stock through accelerated stock repurchase agreements, reflecting strong business growth and commitment to shareholder value. The company is also addressing chronic conditions by introducing innovative solutions like EncircleRx, which offers financial guarantees for managing the cost of GLP-1s.
Partnerships and Community Engagement: Cigna partners with various organizations to enhance community health. This includes sponsoring the NFL's Vincent Country Safe Zone Activity Day, providing essential health screenings and eye exams for students, and participating in behavioral health initiatives through Evernorth Behavioral Care Group.
Financial Performance: Cigna reported strong first-quarter 2024 results, with adjusted income from operations of $1.9 billion, reflecting growth across its Evernorth and Cigna Healthcare businesses. The company also announced pricing terms for tender offers to manage its senior notes, aiming for significant savings for both patients and health plans through biosimilar initiatives.
Future Outlook: As of 2024, Cigna aims to achieve an adjusted EPS growth target of 10%-14% and has reaffirmed its 2024 adjusted EPS guidance of at least $28.25. The company continues to innovate and expand its healthcare offerings, focusing on affordability, access, and improved clinical outcomes.
Cigna Corporation (NYSE: CI) will announce its Q2 2021 financial results on August 5, 2021, at 6:30 a.m. ET. A conference call is scheduled for the same day at 8:30 a.m. ET to discuss the results. Participants are encouraged to join by 8:15 a.m. ET. The call can be accessed via phone or live webcast and a replay will be available starting at 12:30 p.m. ET on August 5 until 11:59 p.m. ET on August 19. Cigna provides integrated health services worldwide, impacting around 190 million customers.
Cigna has appointed Bonnie Evelyn as the new market president for its health care and related benefits plans in Georgia and Alabama, succeeding Bryan Holgerson, who has taken on the role of Chief Underwriting Officer. In her new position, Evelyn will focus on serving clients with over 500 plan employees and enhancing access to affordable health care. With over 25 years of experience, including her current role leading Cigna’s Taft-Hartley and Federal Business segment, her leadership is expected to strengthen Cigna's market position in the region.
On June 30, 2021, Cigna Corporation CEO David Cordani and former President George W. Bush held a fireside chat to honor American veterans and support the Achilles International Freedom Team, comprised of wounded military members. Bush emphasized the resilience of veterans facing both visible and invisible injuries. Cordani praised their athletic accomplishments. The event was part of the 650-mile Achilles Resilience Relay, culminating in New York's Central Park on July 9, 2021. Cigna aims to improve veteran health through its sponsorship of the Achilles Freedom Team.
Evernorth, part of Cigna, is expanding its weight management program to include Wegovy (semaglutide), a newly approved obesity treatment by the FDA. The program offers virtual consultations with MDLIVE physicians, providing patients easier access to medications and support. Key benefits include affordability via value-based arrangements and personalized health coaching. With obesity-related annual costs soaring to $45,514 per patient, this initiative aims to enhance patient adherence and reduce long-term health costs. This comprehensive strategy may improve health outcomes and help manage chronic conditions associated with obesity.
Oscar Health, Inc. (NYSE: OSCR) and Cigna (NYSE: CI) have partnered to offer Cigna Administered by Oscar small group health insurance in Arizona starting July 1, 2021. This initiative aims to support small businesses recovering from the COVID-19 pandemic, which saw 30.2% reporting revenue declines. The partnership offers tailored health plans with cost-saving options, extensive doctor networks, and behavioral health benefits. Both companies will share risk under a reinsurance agreement and plan to expand their collaboration over time, enhancing employee health coverage for small businesses.
Cigna Corporation (NYSE:CI) has announced that Tim Wentworth, CEO of Evernorth, will present at the Goldman Sachs 42nd Annual Healthcare Conference on June 9, 2021, via a virtual webcast. The presentation is set to begin at approximately 11:20 a.m. ET, with a live webcast available on Cigna's investor relations page. This event highlights Cigna's commitment to engaging with investors and providing updates on their integrated health services, which include medical, dental, pharmacy, and more, serving approximately 190 million customers globally.
Cigna reported strong first quarter results for 2021, with total revenues of $41.0 billion and net income of $1.2 billion, or $3.30 per share. Adjusted income from operations was $1.7 billion, or $4.73 per share. The company projects full-year adjusted income from operations to reach at least $7.0 billion, or $20.20 per share. Cigna's customer base grew, with medical customers totaling 16.7 million and pharmacy customers 101.0 million. Despite COVID-19 impacts, the firm showcased strong execution across its business segments.
The Board of Directors of Cigna Corporation (NYSE: CI) has declared a cash dividend of $1.00 per share on April 28, 2021. This dividend will be paid on June 23, 2021 to shareholders on record as of the close of business on June 8, 2021. Cigna emphasizes its commitment to delivering quality health services and maintaining strong shareholder returns through regular dividend payments.
Cigna Corporation (NYSE:CI) will present at the 2021 BofA Securities Health Care Conference on May 13, 2021, around 8:00 a.m. ET. Brian Evanko, Cigna's executive vice president and CFO, will lead the presentation, available via live webcast on Cigna's investor relations page. Cigna is dedicated to enhancing health and well-being through integrated health solutions across more than 30 countries, serving over 175 million customers globally.
Cigna is launching initiatives to enhance access to COVID-19 vaccinations, including paid time off for employees to get vaccinated, a $200 incentive for fully vaccinated staff, and free transportation for Medicare Advantage customers to vaccination sites. These measures aim to support community immunity and reduce health disparities. The company extended the use of emergency time off for COVID-19-related reasons through 2021, with over 875,500 hours already claimed. Cigna's outreach includes direct assistance to vulnerable seniors, reinforcing its commitment to equitable health care.
FAQ
What is the current stock price of The Cigna Group (CI)?
What is the market cap of The Cigna Group (CI)?
What services does The Cigna Group offer?
What is Cigna's primary business focus?
What are some recent achievements of The Cigna Group?
Who are Cigna's key partners?
What are Cigna's future plans?
How does Cigna support community health?
What is Cigna's role in pharmacy benefit management?
What financial initiatives has Cigna undertaken recently?
What are some of Cigna's innovative healthcare solutions?